219 related articles for article (PubMed ID: 21257919)
1. Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.
Cai J; Hong Y; Weng C; Tan C; Imperato-McGinley J; Zhu YS
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1210-21. PubMed ID: 21257919
[TBL] [Abstract][Full Text] [Related]
2. Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells.
Wen J; Zhao Y; Li J; Weng C; Cai J; Yang K; Yuan H; Imperato-McGinley J; Zhu YS
Prostate; 2013 Jul; 73(10):1069-81. PubMed ID: 23423946
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
[TBL] [Abstract][Full Text] [Related]
4. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
Le H; Arnold JT; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
Zhu A; Li Y; Song W; Xu Y; Yang F; Zhang W; Yin Y; Guan X
Cell Physiol Biochem; 2016; 38(3):1003-14. PubMed ID: 26938985
[TBL] [Abstract][Full Text] [Related]
6. The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines.
Katayama H; Murashima T; Saeki Y; Nishizawa Y
Int J Oncol; 2010 Mar; 36(3):553-62. PubMed ID: 20126974
[TBL] [Abstract][Full Text] [Related]
7. Effects of testosterone, dihydrotestosterone, and 17beta-estradiol on human ovarian tissue survival in culture.
Otala M; Mäkinen S; Tuuri T; Sjöberg J; Pentikäinen V; Matikainen T; Dunkel L
Fertil Steril; 2004 Oct; 82 Suppl 3():1077-85. PubMed ID: 15474077
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells.
Weng C; Cai J; Wen J; Yuan H; Yang K; Imperato-McGinley J; Zhu YS
Int J Oncol; 2013 Jan; 42(1):327-37. PubMed ID: 23135751
[TBL] [Abstract][Full Text] [Related]
9. NADPH Oxidase Mediates Membrane Androgen Receptor-Induced Neurodegeneration.
Tenkorang MAA; Duong P; Cunningham RL
Endocrinology; 2019 Apr; 160(4):947-963. PubMed ID: 30811529
[TBL] [Abstract][Full Text] [Related]
10. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells.
Norata GD; Tibolla G; Seccomandi PM; Poletti A; Catapano AL
J Clin Endocrinol Metab; 2006 Feb; 91(2):546-54. PubMed ID: 16317058
[TBL] [Abstract][Full Text] [Related]
12. The antiandrogenic effect of finasteride against a mutant androgen receptor.
Wu Y; Chhipa RR; Zhang H; Ip C
Cancer Biol Ther; 2011 May; 11(10):902-9. PubMed ID: 21386657
[TBL] [Abstract][Full Text] [Related]
13. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells.
Lu S; Wang A; Lu S; Dong Z
Mol Cancer Ther; 2007 Jul; 6(7):2057-64. PubMed ID: 17620434
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor functions as a negative transcriptional regulator of DEPTOR, mTOR inhibitor.
Kanno Y; Zhao S; Yamashita N; Yanai K; Nemoto K; Inouye Y
J Toxicol Sci; 2015 Dec; 40(6):753-8. PubMed ID: 26558456
[TBL] [Abstract][Full Text] [Related]
15. Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis.
Lecce L; Lam YT; Lindsay LA; Yuen SC; Simpson PJ; Handelsman DJ; Ng MK
Mol Endocrinol; 2014 Sep; 28(9):1487-501. PubMed ID: 25058601
[TBL] [Abstract][Full Text] [Related]
16. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells.
Somjen D; Kohen F; Jaffe A; Amir-Zaltsman Y; Knoll E; Stern N
Hypertension; 1998 Jul; 32(1):39-45. PubMed ID: 9674635
[TBL] [Abstract][Full Text] [Related]
17. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.
Eisermann K; Broderick CJ; Bazarov A; Moazam MM; Fraizer GC
Mol Cancer; 2013 Feb; 12():7. PubMed ID: 23369005
[TBL] [Abstract][Full Text] [Related]
18. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
Le HT; Schaldach CM; Firestone GL; Bjeldanes LF
J Biol Chem; 2003 Jun; 278(23):21136-45. PubMed ID: 12665522
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
Segal CV; Koufaris C; Powell C; Gooderham NJ
Toxicology; 2015 Jul; 333():45-52. PubMed ID: 25846647
[TBL] [Abstract][Full Text] [Related]
20. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway.
Death AK; McGrath KC; Sader MA; Nakhla S; Jessup W; Handelsman DJ; Celermajer DS
Endocrinology; 2004 Apr; 145(4):1889-97. PubMed ID: 14684616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
